SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 8th, 2023 • Organicell Regenerative Medicine, Inc. • Biological products, (no disgnostic substances) • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 6, 2023, by and between ORGANICELL REGENERATIVE MEDICINE, INC., a Nevada corporation, with headquarters located at 3321 College Avenue, Suite 246, Davie, FL 33314 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT ORGANICELL REGENERATIVE MEDICINE, INC.Common Stock Purchase Warrant • March 8th, 2023 • Organicell Regenerative Medicine, Inc. • Biological products, (no disgnostic substances) • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $530,000.00 12% promissory note to the Holder (as defined below) of even date) (the “Note”), AJB Capital Investments, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Organicell Regenerative Medicine, Inc., a Nevada corporation (the “Company”), up to 10,000,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 6, 2023, by and
